Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#502 most reported symptom for this vaccine
Gastrointestinal tube insertion has been reported 42 times in association with HPV (Gardasil) vaccination in VAERS. This represents 0.1% of all 44,434 reports for this vaccine.
Among these reports, 7 mentioned death (16.67%) and 32 involved hospitalization (76.2%).
Gastrointestinal tube insertion is the #502 most frequently reported symptom for HPV (Gardasil) out of 2579 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 42 reports of Gastrointestinal tube insertion after HPV (Gardasil) vaccination may seem alarming, but context is critical.
The 16.67% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.